Clinical Trials in Georgia

Showing 15721-15740 of 19,050 trials

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

NCT00917306

The open label study is designed to assess the safety and efficacy of 0.05% PEP005 Gel when applied to an area of skin containing 4-8 AK lesions on non-head locations.

Actinic Keratosis

Peplin102 participantsStarted Jun 2009

Orange Park, Florida, United States • Newnan, Georgia, United States • Snellville, Georgia, United States +8 more locations

COMPLETED63 miles

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

NCT01149551

The purpose of this study is to detect genetic associations for the development of schizophrenia (SZ) and bipolar illness (BP) by comparing Veterans with these diseases to "psychiatrically healthy" Veterans from Veterans Health Administration medical centers. In addition, the genetic basis for functional capacity and disability in Veterans affected with SZ and BP will be assessed, as will genetic predictors of suicidality and tardive dyskinesia. Finally, we will also establish a repository which allows for future genomic studies related to SZ, BP, and related disorders or sequelae.

SchizophreniaBipolar Disorder

US Department of Veterans Affairs9,356 participantsStarted Feb 2011

Birmingham, Alabama, United States • Tuscaloosa, Alabama, United States • No. Little Rock, Arkansas, United States +22 more locations

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

Find Trials by Condition in Georgia

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects

Mechanisms of Mitochondrial Defects in Gulf War Syndrome

Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Effect of Teriparatide on Hip Fracture Healing

Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects

Progressive Intervention Program for Tinnitus Management

CHARITE™ vs. ALIF 5-Year Follow-up

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Dose Escalation of IPI-493 in Hematologic Malignancies

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin